Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dantrolene for Darier disease
2024-519201-36-00Phase 2Completed
- Sponsor
- Karolinska University Hospital
- Start
- Nov 2024
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dantrolene in Darier disease, sponsored by Karolinska University Hospital. Primary endpoint: Change in Physician Global Assessment (PGA) of skin area affected. Started Nov 2024; status: completed.
02
Drugs
dantrolene
03
Conditions
Darier disease
Beyond the preview
Go deeper on 2024-519201-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519201-36-00.